You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fasenra

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India Trial in India (Benralizumab)

Recruiting
  • In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India
  • Benralizumab
  • Bengaluru, India
  • +12 more
Jan 3, 2023

Asthma Trial in Japan

Active, not recruiting
  • Asthma
    • Aichi, Japan
    • +34 more
    Jan 11, 2023

    Fasenra in Patients With Severe Uncontrolled Asthma

    Completed
    • Severe Uncontrolled Asthma
      • (no location specified)
      Apr 6, 2021

      Asthma Attack, Asthma Trial in Singapore (Benralizumab 30 MG/ML [Fasenra], Placebos)

      Recruiting
      • Asthma Attack
      • Asthma
      • Benralizumab 30 MG/ML [Fasenra]
      • Placebos
      • Singapore, Foreign, Singapore
        Singapore General Hospital
      Jul 22, 2021

      Patients With Severe Eosinophilic Asthma and Nasal Polyps.

      Recruiting
      • Severe Eosinophilic Asthma
      • Nasal Polyps
      • FASENRA(benralizumab)
      • Centennial, Colorado
      • +44 more
      Jun 3, 2022

      Eosinophilic Gastritis or Gastroenteritis Trial in Cincinnati (Benralizumab, Placebo)

      Completed
      Has Results
      • Eosinophilic Gastritis or Gastroenteritis
      • Benralizumab
      • Placebo
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jan 27, 2022

      ABPA, Severe Asthma, Allergic Bronchopulmonary Aspergillosis Trial in Dallas (Fasenra, 30 Mg/mL Subcutaneous Solution)

      Withdrawn
      • ABPA
      • +2 more
      • Fasenra, 30 Mg/mL Subcutaneous Solution
      • Dallas, Texas
        Baylor University Medical Center
      Jan 17, 2022

      Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)

      Active, not recruiting
      • Chronic Spontaneous Urticaria
      • Benralizumab
      • Placebo and Benralizumab
      • Scottsdale, Arizona
      • +39 more
      Jan 16, 2023

      Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)

      Active, not recruiting
      • Asthma
      • Severe Eosinophilic Asthma
      • Brest Cedex, France
      • +22 more
      Aug 24, 2022

      Atopic Dermatitis Trial in Worldwide (Benralizumab, Placebo / Benralizumab)

      Terminated
      • Atopic Dermatitis
      • Benralizumab
      • Placebo / Benralizumab
      • Los Angeles, California
      • +50 more
      Jan 4, 2023

      Biological Therapies for Severe Asthma.

      Recruiting
      • Asthma
      • Mepolizumab
      • +4 more
      • Málaga, Spain
        Hospital Civil-Hospital Regional Universitario de Málaga
      Apr 23, 2021

      Chronic Rhinosinusitis (Diagnosis), Nasal Polyps, Eosinophilia Trial in Baltimore (Benralizumab, Placebo)

      Completed
      Has Results
      • Chronic Rhinosinusitis (Diagnosis)
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Jan 20, 2021

      Asthma Trial in Worldwide (Benralizumab)

      Recruiting
      • Asthma
      • Benralizumab
      • Denver, Colorado
      • +38 more
      Jan 18, 2023

      Asthma; Eosinophilic Trial in London (Benralizumab, 129 Xenon)

      Active, not recruiting
      • Asthma; Eosinophilic
      • London, Ontario, Canada
        Robarts Research Insitute; The University of Western Ontario; Lo
      Sep 18, 2020

      Bullous Pemphigoid Trial in Worldwide (Benralizumab, Placebo)

      Recruiting
      • Bullous Pemphigoid
      • Benralizumab
      • Placebo
      • Phoenix, Arizona
      • +66 more
      Nov 18, 2022

      Interaction Between Benralizumab and Basophils in Eosinophilic

      Not yet recruiting
      • Asthma; Eosinophilic
      • BENRALIZUMAB
      • (no location specified)
      Aug 25, 2021

      Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in Worldwide (Benralizumab, Placebo)

      Recruiting
      • Eosinophilic Gastritis
      • Eosinophilic Gastroenteritis
      • Benralizumab
      • Placebo
      • Phoenix, Arizona
      • +85 more
      Aug 4, 2022

      Benralizumab in Real-World Use in Severe Eosinophilic Asthma

      Recruiting
      • Asthma
        • Changhua City, Taiwan
        • +7 more
        Feb 16, 2023

        Asthma Trial in Worldwide (Benralizumab, Placebo)

        Recruiting
        • Asthma
        • Benralizumab
        • Placebo
        • Los Angeles, California
        • +35 more
        Feb 1, 2023

        Asthma Trial in Worldwide (Benralizumab)

        Completed
        Has Results
        • Asthma
        • Benralizumab
        • Flagstaff, Arizona
        • +143 more
        Jun 22, 2022

        COPD Trial in Worldwide (Benralizumab, Placebo)

        Recruiting
        • Chronic Obstructive Pulmonary Disease
        • Benralizumab
        • Placebo
        • Montgomery, Alabama
        • +400 more
        Jan 11, 2023

        Capture Clinical and Patient Centered Outcomes in Severe

        Recruiting
        • Severe Eosinophilic Asthma
        • Alexandroupolis, Greece
        • +15 more
        Aug 5, 2022

        Nasal Polyposis Trial in Worldwide (Benralizumab 30 mg SC + Mometasone Furoate, Matching SC + Mometasone Furoate)

        Completed
        Has Results
        • Nasal Polyposis
        • Benralizumab 30 mg SC + Mometasone Furoate
        • Matching placebo SC + Mometasone Furoate
        • Birmingham, Alabama
        • +98 more
        Oct 8, 2021